Multiple Sclerosis Clinical Trial
The Gilenya Pregnancy Registry
Summary
The purpose of the Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis (MS) is to continuously monitor, evaluate, and assess for major and minor teratogenic effects in the offspring of women exposed to fingolimod before (up to 8 weeks before last menstrual period (LMP)) and during pregnancy in routine clinical practice. The overall aim is to collect and evaluate data on maternal, fetal, and infant outcomes and compare it with reference populations.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Any woman with a diagnosis of MS
Any woman currently pregnant
Exposure to fingolimod during pregnancy or up to 8 weeks before LMP
Signed informed consent
Exclusion Criteria:
There are no specific exclusion criteria for this registry.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There are 59 Locations for this study
See Locations Near You
Novartis Investigative Site
Fort Lauderdale Florida, 33308, United States
Fort Lauderdale Florida, 33308, United States
Novartis Investigative Site
Cambridge Massachusetts, 02139, United States
Cambridge Massachusetts, 02139, United States
Novartis Investigative Site
Grand Forks North Dakota, 58201, United States
Grand Forks North Dakota, 58201, United States
Novartis Investigative Site
Bahía Blanca Buenos Aires, 8000, Argentina
Bahía Blanca Buenos Aires, 8000, Argentina
Novartis Investigative Site
Cordoba , X5000, Argentina
Cordoba , X5000, Argentina
Novartis Investigative Site
Box Hill Victoria, 3128, Australia
Box Hill Victoria, 3128, Australia
Novartis Investigative Site
Graz , 8036, Austria
Graz , 8036, Austria
Novartis Investigative Site
Linz , 4020, Austria
Linz , 4020, Austria
Novartis Investigative Site
Brasschaat , 2930, Belgium
Brasschaat , 2930, Belgium
Novartis Investigative Site
Leuven , 3000, Belgium
Leuven , 3000, Belgium
Novartis Investigative Site
Melsbroek , 1820, Belgium
Melsbroek , 1820, Belgium
Novartis Investigative Site
Rio de Janeiro RJ, 21941, Brazil
Rio de Janeiro RJ, 21941, Brazil
Novartis Investigative Site
Saint-Laurent Quebec, H4M-2, Canada
Saint-Laurent Quebec, H4M-2, Canada
Novartis Investigative Site
Bogotá , , Colombia
Bogotá , , Colombia
Novartis Investigative Site
Nicosia , 1683, Cyprus
Nicosia , 1683, Cyprus
Novartis Investigative Site
Ostrava-Poruba , 708 5, Czechia
Ostrava-Poruba , 708 5, Czechia
Novartis Investigative Site
Aalborg , 9000, Denmark
Aalborg , 9000, Denmark
Novartis Investigative Site
Aarhus , 8000 , Denmark
Aarhus , 8000 , Denmark
Novartis Investigative Site
Copenhagen , DK-21, Denmark
Copenhagen , DK-21, Denmark
Novartis Investigative Site
Soenderborg , 6400, Denmark
Soenderborg , 6400, Denmark
Novartis Investigative Site
Tampere , FIN-3, Finland
Tampere , FIN-3, Finland
Novartis Investigative Site
Turku , 20520, Finland
Turku , 20520, Finland
Novartis Investigative Site
Bron , 69677, France
Bron , 69677, France
Novartis Investigative Site
Cahors , 50269, France
Cahors , 50269, France
Novartis Investigative Site
Bochum , 44791, Germany
Bochum , 44791, Germany
Novartis Investigative Site
Athens GR, 115 2, Greece
Athens GR, 115 2, Greece
Novartis Investigative Site
Budapest HUN, 1204, Hungary
Budapest HUN, 1204, Hungary
Novartis Investigative Site
Gyor , H-902, Hungary
Gyor , H-902, Hungary
Novartis Investigative Site
Dublin 4 , D04 T, Ireland
Dublin 4 , D04 T, Ireland
Novartis Investigative Site
Jerusalem , 91120, Israel
Jerusalem , 91120, Israel
Novartis Investigative Site
Ramat Gan , 52621, Israel
Ramat Gan , 52621, Israel
Novartis Investigative Site
Catania CT, 95123, Italy
Catania CT, 95123, Italy
Novartis Investigative Site
Firenze FI, 50134, Italy
Firenze FI, 50134, Italy
Novartis Investigative Site
Genova GE, 16132, Italy
Genova GE, 16132, Italy
Novartis Investigative Site
Milano MI, 20132, Italy
Milano MI, 20132, Italy
Novartis Investigative Site
Roma RM, 189, Italy
Roma RM, 189, Italy
Novartis Investigative Site
Orbassano TO, 10043, Italy
Orbassano TO, 10043, Italy
Novartis Investigative Site
Beirut , 1107 , Lebanon
Beirut , 1107 , Lebanon
Novartis Investigative Site
Mexico Distrito Federal, 05300, Mexico
Mexico Distrito Federal, 05300, Mexico
Novartis Investigative Site
Amsterdam , , Netherlands
Amsterdam , , Netherlands
Novartis Investigative Site
Bergen , 5021, Norway
Bergen , 5021, Norway
Novartis Investigative Site
Lubin , 20-08, Poland
Lubin , 20-08, Poland
Novartis Investigative Site
Warszawa , 02-95, Poland
Warszawa , 02-95, Poland
Novartis Investigative Site
Amadora , 2720-, Portugal
Amadora , 2720-, Portugal
Novartis Investigative Site
Porto , 4099-, Portugal
Porto , 4099-, Portugal
Novartis Investigative Site
Bucharest , 05009, Romania
Bucharest , 05009, Romania
Novartis Investigative Site
Moscow , 12701, Russian Federation
Moscow , 12701, Russian Federation
Novartis Investigative Site
Riyadh SAU, 11525, Saudi Arabia
Riyadh SAU, 11525, Saudi Arabia
Novartis Investigative Site
Jeddah , 21499, Saudi Arabia
Jeddah , 21499, Saudi Arabia
Novartis Investigative Site
Riyadh , 11211, Saudi Arabia
Riyadh , 11211, Saudi Arabia
Novartis Investigative Site
Bratislava Slovak Republic, 811 0, Slovakia
Bratislava Slovak Republic, 811 0, Slovakia
Novartis Investigative Site
Maribor , 2000, Slovenia
Maribor , 2000, Slovenia
Novartis Investigative Site
Sevilla Andalucia, 41071, Spain
Sevilla Andalucia, 41071, Spain
Novartis Investigative Site
Madrid , 28222, Spain
Madrid , 28222, Spain
Novartis Investigative Site
Goeteborg , 413 4, Sweden
Goeteborg , 413 4, Sweden
Novartis Investigative Site
Basel , 4031, Switzerland
Basel , 4031, Switzerland
Novartis Investigative Site
Bern , 3010, Switzerland
Bern , 3010, Switzerland
Novartis Investigative Site
Lausanne , 1011, Switzerland
Lausanne , 1011, Switzerland
Novartis Investigative Site
St Gallen , 9007, Switzerland
St Gallen , 9007, Switzerland
Novartis Investigative Site
Abu Dhabi , , United Arab Emirates
Abu Dhabi , , United Arab Emirates
Novartis Investigative Site
Dubai , , United Arab Emirates
Dubai , , United Arab Emirates
Novartis Investigative Site
Newcastle upon Tyne , NE1 4, United Kingdom
Newcastle upon Tyne , NE1 4, United Kingdom
Novartis Investigative Site
Norwich , NR1 3, United Kingdom
Norwich , NR1 3, United Kingdom
Novartis Investigative Site
Nottingham , NG7 2, United Kingdom
Nottingham , NG7 2, United Kingdom
How clear is this clinincal trial information?